Insights

Insights

Stelis_FDA_Banner1

Stelis’ flagship facility receives Establishment Inspection Report from USFDA for Drug Product Manufacturing

Stelis Biopharma Limited, the biologics arm of Strides Pharma Science Limited

no
Facility

Stelis Biopharma receives EU-GMP certification for two of its manufacturing facilities

Stelis Biopharma, the biologics arm of Strides Pharma Science announced that

no
Stelis Next Phase

COVID impact report 

January 2021 In 2020 the Coronavirus pandemic has, unsurprisingly, proved to

no
i-picked hack of a time

I Picked A Heck Of A Time

A new CEO’s observations on managing a fast-growing, fully integrated biophar

no
Unit 2 Bangalore

Stelis starts next phase of investment into its biologics manufacturing facility

This phase sees the CDMO start work on installing two 2,000-L single-use bior

no
south-bangalore-1

Unit 1 – Bangalore, India

State-of-the-art process and analytical development facilities for small-scal

no
north-bangalore

Unit 2 – Bangalore, India

Integrated state-of-the-art manufacturing facility leverages microbial and ma

no
Unit-3 Bangalore

Unit 3 – Bangalore, India

A multipurpose facility with an ability to cater to multiple vaccine types in

no

Our Corporate Governance









    captcha









      captcha